"Receptors, Bradykinin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors that bind BRADYKININ and related KININS with high affinity and trigger intracellular changes which influence the behavior of cells. The identified receptor types (B-1 and B-2, or BK-1 and BK-2) recognize endogenous KALLIDIN; t-kinins; and certain bradykinin fragments as well as bradykinin itself.
Descriptor ID |
D018002
|
MeSH Number(s) |
D12.776.543.750.695.080 D12.776.543.750.720.600.220 D12.776.543.750.750.555.220
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Bradykinin".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Bradykinin [D12.776.543.750.695.080]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Neuropeptide [D12.776.543.750.720.600]
- Receptors, Bradykinin [D12.776.543.750.720.600.220]
- Receptors, Peptide [D12.776.543.750.750]
- Receptors, Neuropeptide [D12.776.543.750.750.555]
- Receptors, Bradykinin [D12.776.543.750.750.555.220]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Bradykinin".
This graph shows the total number of publications written about "Receptors, Bradykinin" by people in this website by year, and whether "Receptors, Bradykinin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2019 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Receptors, Bradykinin" by people in Profiles.
-
A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications. Vascul Pharmacol. 2021 04; 137:106826.
-
Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight? Iran J Allergy Asthma Immunol. 2020 May 17; 19(S1):13-17.
-
A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications. FASEB J. 2020 06; 34(6):7265-7269.
-
Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2. Drug Dev Res. 2020 11; 81(7):765-767.
-
Binding to carboxypeptidase M mediates protective effects of fibrinopeptide Bß15-42. Transl Res. 2019 11; 213:124-135.